Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
144 hedge funds and large institutions have $264M invested in Spectrum Pharmaceuticals Inc in 2016 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 59 increasing their positions, 46 reducing their positions, and 29 closing their positions.
143% more call options, than puts
Call options by funds: $632K | Put options by funds: $260K
28% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 46
11% less funds holding
Funds holding: 161 → 144 (-17)
29% less capital invested
Capital invested by funds: $373M → $264M (-$109M)
59% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.53M |
| 2 |
Renaissance Technologies
New York
|
+$5.83M |
| 3 |
State Street
Boston,
Massachusetts
|
+$2.83M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.39M |
| 5 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$1.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$9.32M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$5.3M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.38M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.56M |
| 5 |
SCA
Secor Capital Advisors
New York
|
-$1.44M |
SPPI Hedge Fund Activity: Q3 2016 in Review
144 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2016, worth a combined $264M — down 29% from $373M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of SPPI and 12 opened new positions — a net loss of 17 holders — while 46 trimmed existing stakes and 59 added.
The largest buyer was BlackRock Fund Advisors, adding an estimated $8.53M. The largest seller was Macquarie Group, cutting an estimated $9.32M.
- 144 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2016, down from 161 in Q2 2016.
- Funds reported $264M of Spectrum Pharmaceuticals Inc stock for Q3 2016, down 29% quarter-over-quarter.
- 12 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2016 and 29 closed out, a net change of -17 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q3 2016 was BlackRock Fund Advisors, an estimated $8.53M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q3 2016 was Macquarie Group, an estimated $9.32M sold.
Based on aggregated 13F filings for Q3 2016.